In conclusion, our study demonstrated mRNA expression of PD‐L1, PD‐1 and CTLA‐4 by both neoplastic and immune cells in canine OMs, supporting their role in immunosuppression and in promoting tumour progression. Here, CTLA4 is linked to opsoclonus-myoclonus syndrome.